Evidence map›Paper›PMID 40336733›Full record

ArticleIJU case reports2025

Diagnosis of Hereditary Leiomyomatosis and Renal Cell Cancer After Subcapsular Renal Hematoma.

Kazuma Soya, Takeru Fujimoto, Daisuke Takahashi, Kana Kohashiguchi, Yusuke Takei, Yoshio Sugino, Hiroshi Iwamura

Abstract read
In one paragraph

Article in IJU case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kazuma SoyaDepartment of Urology National Hospital Organization Himeji Medical Center Himeji Hyogo Japan.ORCID https://orcid.org/0009-0000-5390-2831
Takeru FujimotoDepartment of Urology National Hospital Organization Himeji Medical Center Himeji Hyogo Japan.ORCID https://orcid.org/0000-0002-1576-2927
Daisuke TakahashiDepartment of Urology National Hospital Organization Himeji Medical Center Himeji Hyogo Japan.
Kana KohashiguchiDepartment of Urology National Hospital Organization Himeji Medical Center Himeji Hyogo Japan.
Yusuke TakeiDepartment of Diagnostic Pathology National Hospital Organization Himeji Medical Center Himeji Hyogo Japan.
Yoshio SuginoDepartment of Urology National Hospital Organization Himeji Medical Center Himeji Hyogo Japan.
Hiroshi IwamuraDepartment of Urology National Hospital Organization Himeji Medical Center Himeji Hyogo Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Hereditary leiomyomatosis and renal cell cancer (HLRCC) is a rare autosomal dominant genetic disorder. We report a case diagnosed with HLRCC following a subcapsular renal hematoma caused by a tumor. Case Presentation: A 28-year-old woman with a history of uterine myomas presented with left back pain. Computed tomography revealed a renal mass with a subcapsular hematoma, and coil embolization was performed. The tumor had enlarged rapidly, and Conclusion: A combination of imaging tests using multiple modalities and close follow-ups contributed to establishing an accurate diagnosis and providing early definitive treatment.

Indexed as

fumarate hydratasehematomahereditary leiomyomatosis and renal cell cancerpapillary renal cell carcinomapositron emission tomography computed tomography

Identifiers

PMID40336733
PMCPMC12055208

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.